Thyroid modifications in male and female rats treated with the hepatocarcinogen beta-blocker ZAMI 1305
- 1 July 1983
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 19 (3) , 293-299
- https://doi.org/10.1016/0304-3835(83)90097-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Liver Tumors Induced by a New Beta-Adrenoreceptor Blocking Agent in Female Rats23JNCI Journal of the National Cancer Institute, 1982
- The Effects of Propranolol on Thyroxine Metabolism and Triiodothyronines Production in ManThe Journal of Clinical Pharmacology, 1982
- THYROID-ACTIVITY DURING HEPATOCARCINOGENESIS BY N-2-FLUORENYLACETAMIDE IN THE MALE-RAT1982
- Thyroxine Binding Globulin and Thyroid Function Tests in Patients with Hepatocellular CarcinomaHepatology, 1982
- Thyroid activity during hepatocarcinogenesis by N-2-fluorenylacetamideZeitschrift für Krebsforschung und Klinische Onkologie, 1981
- INHIBITION OF LOCAL AND METASTATIC HEPATOMA GROWTH AND PROLONGATION OF SURVIVAL AFTER INDUCTION OF HYPOTHYROIDISM1981
- INVOLVEMENT OF THE IODOTHYRONINES IN LIVER AND HEPATOMA-CELL PROLIFERATION IN THE RAT1980
- Inhibition of the growth of Morris Hepatoma #44 in rats after induction of hypothyroidism: Evidence that Morris Hepatomas are thyroid dependentGastroenterology, 1979
- INCREASED SURVIVAL OF RATS BEARING MORRIS HEPATOMA 7800 AFTER INDUCTION OF HYPO-THYROIDISM1979
- HEPATIC CARCINOGENESIS IN THYROIDECTOMIZED RATS - APPARENT BLOCKADE AT STAGE OF INITIATION1966